Wei Xiaodan, Huang Honglin, Guo Junhan, Li Ningxi, Li Qingzhi, Zhao Tian, Yang Geng, Cai Lulu, Yang Hong, Wu Chunhui, Liu Yiyao
Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, and School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610054, P. R. China.
TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, No. 39 Shi-er-qiao Road, Chengdu, Sichuan, 610072, P. R. China.
Small. 2023 Dec;19(49):e2304370. doi: 10.1002/smll.202304370. Epub 2023 Aug 16.
Reprogramming the immunologically "cold" environment of solid tumors is currently becoming the mainstream strategy to elicit powerful and systemic anticancer immunity. Here, a facile and biomimetic nano-immunnoactivator (CuS/Z@M ) is detailed by engineering a Zn -bonded zeolitic imidazolate framework-8 (ZIF-8) with CuS nanodots (NDs) and cancer cell membrane for amplified near-infrared-II (NIR-II) photothermal immunotherapy via Zn metabolic modulation. Taking advantage of the NIR-II photothermal effect of CuS NDs and the acidic responsiveness of ZIF-8, CuS/Z@M rapidly causes intracellular Zn pool overload and disturbs the metabolic flux of 4T1 cells, which effectively hamper the production of heat shock proteins and relieve the resistance of photothermal therapy (PTT). Thus, amplified immunogenic cell death is evoked and initiates the immune cascade both in vivo and in vitro as demonstrated by dendritic cells maturation and T-cell infiltration. Further combination with antiprogrammed death 1 (aPD-1) achieves escalated antitumor efficacy which eliminates the primary, distant tumor and avidly inhibits lung metastasis due to cooperation of enhanced photothermal stimulation and empowerment of cytotoxic T lymphocytes by aPD-1. Collectively, this work provides the first report of using the intrinsic modulation property of meta-organometallic ZIF-8 for enhanced cancer photoimmunotherapy together with aPD-1, thereby inspiring a novel combined paradigm of ion-rich nanomaterials for cancer treatment.
重编程实体瘤的免疫“冷”环境目前正成为引发强大全身抗癌免疫的主流策略。在此,通过用硫化铜纳米点(NDs)和癌细胞膜对锌键合沸石咪唑酯骨架-8(ZIF-8)进行工程设计,详细介绍了一种简便的仿生纳米免疫激活剂(CuS/Z@M),以通过锌代谢调节实现放大的近红外二区(NIR-II)光热免疫治疗。利用硫化铜纳米点的NIR-II光热效应和ZIF-8的酸响应性,CuS/Z@M迅速导致细胞内锌池过载并扰乱4T1细胞的代谢通量,有效阻碍热休克蛋白的产生并减轻光热疗法(PTT)的抗性。因此,引发了放大的免疫原性细胞死亡,并在体内和体外启动免疫级联反应,如树突状细胞成熟和T细胞浸润所示。进一步与抗程序性死亡1(aPD-1)联合使用可实现增强的抗肿瘤疗效,由于增强的光热刺激与aPD-1增强细胞毒性T淋巴细胞的协同作用,消除了原发性和远处肿瘤,并强烈抑制肺转移。总的来说,这项工作首次报道了利用金属有机ZIF-8的内在调节特性与aPD-1一起增强癌症光免疫治疗,从而激发了一种用于癌症治疗的富含离子纳米材料的新型联合模式。